Relmada Therapeutics, Inc. (RLMD)
2.62
-0.49
(-15.76%)
USD |
NASDAQ |
Nov 20, 16:00
2.615
0.00 (0.00%)
After-Hours: 20:00
Relmada Therapeutics Cash and Short Term Investments (Annual) : 93.01M for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 93.01M |
| December 31, 2024 | 44.91M |
| December 31, 2023 | 96.32M |
| December 31, 2022 | 148.32M |
| December 31, 2021 | 211.91M |
| December 31, 2020 | 117.09M |
| June 30, 2019 | 9.217M |
| Date | Value |
|---|---|
| June 30, 2018 | 2.239M |
| June 30, 2017 | 1.710M |
| June 30, 2016 | 8.500M |
| June 30, 2015 | 22.47M |
| June 30, 2014 | 25.56M |
| December 31, 2013 | 3.522M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| Talphera, Inc. | 20.38M |
| Journey Medical Corp. | 24.09M |
| ANI Pharmaceuticals, Inc. | 294.75M |
| Corcept Therapeutics, Inc. | 372.15M |
| Veru, Inc. | 18.32M |